Lisata Therapeutics, Inc. last reported quarterly results on Nov 6, 2025, for Q3 FY2025 (the quarter ended Sep 30, 2025): revenue of $0 and diluted EPS of -$0.49. It usually reports 37–58 days after a quarter ends.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 37–58 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Nov 6, 2025
37 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
0
|
-4
+13.8%
|
-0.49
+16.9%
|
|
Aug 7, 2025
38 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
0
|
-5
+7.6%
|
-0.54
+11.5%
|
|
May 8, 2025
38 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
0
|
-5
+12.5%
|
-0.55
+15.4%
|
|
Feb 27, 2025
58 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
1
|
-5
+14.1%
|
-0.55
+16.7%
|
|
Nov 12, 2024
43 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
0
|
-5
+6.3%
|
-0.59
+9.2%
|
|
Aug 12, 2024
43 days after quarter end
|
Q2 FY2024
ended Jun 30, 2024
|
0
|
-5
-25.3%
|
-0.61
-22.0%
|
|
May 9, 2024
39 days after quarter end
|
—
ended Mar 31, 2024
|
—
|
—
|
—
|
|
Feb 29, 2024
60 days after quarter end
|
—
ended Dec 31, 2023
|
—
|
—
|
—
|
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LSTA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Basking Ridge, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 320017
- Former names
- Caladrius Biosciences, Inc. (until Sep 15, 2022); CALADRIUS BIOSCIENCES, INC. (until Sep 15, 2022); NeoStem, Inc. (until Jun 5, 2015); PHASE III MEDICAL INC/DE (until Sep 1, 2006); CORNICHE GROUP INC /DE (until Aug 14, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.